Milestone Pharmaceuticals Inc. (MIST) Financials
MIST Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 87.1 million | 58.6 million |
2023-06-30 | 97.0 million | 56.6 million |
2023-03-31 | 111.1 million | 57.1 million |
2022-12-31 | 74.5 million | 8.1 million |
MIST Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.2 million | 2.9 million |
2023-06-30 | -10.6 million | 2.5 million |
2023-03-31 | -13.9 million | 2.3 million |
2022-12-31 | -13.0 million | 2.1 million |
MIST Net Income
No data available :(
MIST Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 75.7 million | - | 2.1 million |
2023-06-30 | 87.6 million | 48.1 million | 2.3 million |
2023-03-31 | 101.0 million | 47.3 million | 2.4 million |
2022-12-31 | 64.6 million | - | 2.5 million |
MIST Shares Outstanding
MIST Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 18000 | 6.7 million | 4.2 million | 4.4 million |
2023-06-30 | 31000 | 8.6 million | 4.4 million | 3.4 million |
2023-03-31 | 32000 | 10.3 million | 3.9 million | 2.4 million |
2022-12-31 | 110000 | 10.6 million | 4.1 million | 2.6 million |
MIST Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 23999 |
2023-06-30 | - | 24000 |
2023-03-31 | 1.0 million | 18000 |
2022-12-31 | 3.5 million | 406000 |
MIST
Price: $1.74
52 week price:
Earnings Per Share: -1.39 USD
P/E Ratio: -1.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 563278
Market Capitalization: 90.1 million